University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
Cancer Research UK Cambridge Institute, Department of Chemistry, Department of Chemical Engineering and Biotechnology
CRUK Cambridge Institute
New synergies between magnetic hyperthermia and drug delivery for cancer therapy.
PI: Andrew Wheatley.
Co-PI: David Fairen-Jimenez.
Wellcome Trust Sanger Institute
Not applicable/other
Addenbrooke's Hospital, CUH NHS Foundation Trust
University of Cambridge, AstraZeneca
Department of Chemical Engineering and Biotechnology
University of Cambridge, GlaxoSmithKline
Department of Engineering, Department of Physiology, Development and Neuroscience, Department of Haematology
CRUK Cambridge Institute
Ahsan has developed a sui generis versatile holographic system capable of diverse photo-perturbation techniques including photo-...
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
NHS-Blood and Transplant
The Méndez-Ferrer laboratory research focuses on the regulation of the haematopoietic stem-cell niche in health and disease. Blood stem...
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Department of Radiology
Cambridge University Hospitals NHS Foundation Trust | Addenbrooke's Hospital
I am interested in multiparametric multimodality imaging of cancer, imaging biomarker development, the translation of novel radiolabelled...
University of Cambridge
Cancer Research UK Cambridge Institute
CRUK Cambridge Institute
I am a PhD student working with Cancer Research UK RadNet Cambridge Radiation Research Centre of Excellence.
